PhaseBio Pharmaceuticals, Inc. (PHAS)
SBC to Revenue
20939.89%
TTM · Retrieved:
PHAS SBC to Revenue
Current (TTM)20939.89%retrieved
Current (TTM)20939.89%retrieved
PHAS SBC/Revenue (0.00% → 20939.89%)
Latest values, visible window
High-resolution chart · PNG
PHAS sbc to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 20,939.8947% | |
| 699.0625% | |
| 60.1864% | |
| 49.7006% | |
| 0% | |
| 0% |